Literature DB >> 23970632

Prevalence of and risk factors for osteoporosis and fracture among a male HIV-infected population in the UK.

Charlotte-Eve S Short1, Simon G Shaw, Martin J Fisher, Karen Walker-Bone, Yvonne C Gilleece.   

Abstract

Rates of osteoporosis and fracture may be increased in HIV but there are few UK data. Our aim was to examine the prevalence of and risk factors for osteoporosis and fractures among a homogeneous cohort of well-characterized HIV-infected men. In total, 168 men were recruited, median age 45 years, 37 combination antiretroviral therapy (cART) naïve, 46 with <3 years cART exposure and 85 cART-exposed longer term (median >10 years). All participants provided information on bone health and underwent DEXA scanning. Osteopenia was found in 58% of subjects and osteoporosis in 12%; 14% reported fractures since HIV diagnosis. Number of fractures since HIV diagnosis was significantly increased among those with osteoporosis (OR 3.5, 95% CI 1.2-10.4, p = 0.018). Duration of infection greater than 13 years was significantly associated with osteoporosis. Duration of cART was associated in univariate but not multivariate analyses. Strategies to prevent osteoporosis and fractures in HIV will require attention to viral and lifestyle factors and not just cART.

Entities:  

Keywords:  DEXA; HIV; Osteoporosis; ageing; antiretroviral therapy; bone density; fractures; male; osteopenia

Mesh:

Year:  2013        PMID: 23970632      PMCID: PMC5362062          DOI: 10.1177/0956462413492714

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  29 in total

1.  Epidemiology of osteoporosis.

Authors:  C Cooper
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

2.  Longitudinal analysis of bone density in human immunodeficiency virus-infected women.

Authors:  Sara E Dolan; Jenna R Kanter; Steven Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

3.  A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience.

Authors:  L Waters; B Patterson; A Scourfield; A Hughes; S de Silva; B Gazzard; S Barton; D Asboe; A Pozniak; M Boffito
Journal:  Int J STD AIDS       Date:  2012-08       Impact factor: 1.359

4.  Reduced bone mineral density in HIV-positive individuals.

Authors:  A L Moore; A Vashisht; C A Sabin; A Mocroft; S Madge; A N Phillips; J W Studd; M A Johnson
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

Review 5.  Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.

Authors:  Todd T Brown; Roula B Qaqish
Journal:  AIDS       Date:  2006-11-14       Impact factor: 4.177

6.  Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.

Authors:  William Rosner; Richard J Auchus; Ricardo Azziz; Patrick M Sluss; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

7.  Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.

Authors:  Benjamin Young; Christine N Dao; Kate Buchacz; Rose Baker; John T Brooks
Journal:  Clin Infect Dis       Date:  2011-03-10       Impact factor: 9.079

8.  Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.

Authors:  Dario Bruera; Norma Luna; Daniel O David; Liliana M Bergoglio; Javier Zamudio
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

9.  Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.

Authors:  Virginia A Triant; Todd T Brown; Hang Lee; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2008-07-01       Impact factor: 5.958

10.  Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study.

Authors:  J Prior; D Burdge; E Maan; R Milner; C Hankins; M Klein; S Walmsley
Journal:  Osteoporos Int       Date:  2007-07-31       Impact factor: 4.507

View more
  12 in total

1.  Bone alterations associated with HIV.

Authors:  Amy H Warriner; Michael Mugavero; E Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

2.  Pituitary growth hormone (GH) secretion is partially rescued in HIV-infected patients with GH deficiency (GHD) compared to hypopituitary patients.

Authors:  Chiara Diazzi; Giulia Brigante; Giulia Ferrannini; Anna Ansaloni; Lucia Zirilli; Maria Cristina De Santis; Stefano Zona; Giovanni Guaraldi; Vincenzo Rochira
Journal:  Endocrine       Date:  2016-10-11       Impact factor: 3.633

3.  Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.

Authors:  D Santi; B Madeo; F Carli; S Zona; G Brigante; F Vescini; G Guaraldi; V Rochira
Journal:  Osteoporos Int       Date:  2015-10-28       Impact factor: 4.507

4.  Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.

Authors:  Julie J Kim-Chang; Lorena Wilson; Cliburn Chan; Bernard Fischer; Guglielmo Venturi; Maureen M Goodenow; Grace Aldrovandi; Thomas J Weber; John W Sleasman
Journal:  AIDS Res Hum Retroviruses       Date:  2019-06-27       Impact factor: 2.205

Review 5.  Vitamin D and bone loss in HIV.

Authors:  Corrilynn O Hileman; Edgar T Overton; Grace A McComsey
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

6.  Bone Loss in HIV Infection.

Authors:  Caitlin A Moran; M Neale Weitzmann; Ighovwerha Ofotokun
Journal:  Curr Treat Options Infect Dis       Date:  2017-02-23

Review 7.  Bone loss in HIV: a contemporary review.

Authors:  Corrilynn O Hileman; Allison Ross Eckard; Grace A McComsey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-12       Impact factor: 3.243

Review 8.  Bone mineral density in people living with HIV: a narrative review of the literature.

Authors:  M J Kruger; T A Nell
Journal:  AIDS Res Ther       Date:  2017-07-26       Impact factor: 2.250

Review 9.  Bone health and HIV in resource-limited settings: a scoping review.

Authors:  Flavia Kiweewa Matovu; Lalita Wattanachanya; Mags Beksinska; John M Pettifor; Kiat Ruxrungtham
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

10.  HIV and Vertebral Fractures: a Systematic Review and Metanalysis.

Authors:  Thales A S H Ilha; Fabio V Comim; Rafaela M Copes; Juliet E Compston; Melissa O Premaor
Journal:  Sci Rep       Date:  2018-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.